Opportunity
Simpler Grants.gov #RFA-DK-27-107
NIH Solicitation for National K12 Program in Diabetes Research Career Development
Buyer
National Institutes of Health
Posted
December 29, 2025
Respond By
July 01, 2026
Identifier
RFA-DK-27-107
NAICS
541715
The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is inviting applications for the National K12 Program for Career Development of Clinician-Scientists in Diabetes Research (Diabetes-DOCS). - Program Overview: - Supports career development of physicians, especially pediatric endocrinologists and related specialists, in innovative diabetes research - Primary focus on Type 1 Diabetes, with potential expansion to Type 2 Diabetes research in the second year if additional funds are available - Funding Structure: - One national administrative center will be funded - Scholars will be appointed and supported at their respective home institutions across the United States - Participation and Eligibility: - Open to government entities, nonprofits, educational institutions, tribal organizations, and foreign institutions - Scholars may participate in clinical trials under experienced mentors but cannot serve as lead investigators of independent clinical trials - Notable Details: - No specific OEMs, vendors, or commercial products/services are being procured; this is a research grant opportunity - The program is designed to build a national network of clinician-scientists in diabetes research
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) seeks to fund a program supporting the career development of physicians committed to diabetes research, focusing primarily on Type 1 Diabetes. The program aims to increase the number of physician scientists with independent research careers aligned with NIDDK's mission. Scholars will be appointed at their home institutions nationwide and may engage in clinical trials led by experienced mentors, but cannot serve as lead investigators of independent clinical trials. The program may expand to include Type 2 Diabetes research in its second year if additional funds are available.